首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷藥物遞輸設備電子醫療設備內視鏡檢查設備

智慧藥丸技術市場規模、佔有率和成長分析（按目標領域、適應症、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898427

智慧藥丸技術市場規模、佔有率和成長分析（按目標領域、適應症、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

Smart Pills Technology Market Size, Share, and Growth Analysis, By Target Area (Esophagus, Stomach), By Disease Indication (Barrett's Esophagus, Small Bowel Diseases), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 264 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球智慧藥丸技術市場規模預計在 2024 年達到 42.3 億美元，從 2025 年的 45.9 億美元成長到 2033 年的 88.2 億美元，在預測期（2026-2033 年）內複合年成長率為 8.5%。

全球智慧藥丸技術市場正見證著創新數位膠囊在先進感測、成像和藥物傳輸領域的廣泛應用。這些膠囊配備有生物感測器和pH感測器等多種感測器，可在胃腸道內移動，捕捉傳統方法難以取得的重要診斷影像。此外，可連接的穿戴式感測器貼片，結合醫療服務提供者的入口網站和行動應用程式，增強了監測能力，並為內視鏡等傳統診斷技術提供了非侵入性替代方案，尤其是在癌症和胃腸道疾病的診斷方面。智慧藥丸還能提高患者的用藥依從性，並有助於評估胃輕癱等胃腸道疾病。這些技術能夠無線傳輸包括生命徵象和胃腸道指標在內的關鍵數據，正在革新患者的診斷和管理，為醫療服務提供者帶來更大的柔軟性。

全球智慧藥丸技術市場促進因素

由於胃腸道疾病（包括動力障礙、大腸直腸癌、不明原因的消化道出血和克隆氏症）的發生率不斷上升，全球智慧藥丸技術市場預計將迎來顯著成長。此外，久坐不動的生活方式也推動了醫療保健領域對創新解決方案的需求。智慧藥丸的優點在於其微創性，有助於提高患者的依從性。隨著技術的不斷進步，這些因素共同推動了人們對智慧藥丸解決方案的興趣，使其成為旨在改善患者預後和提高治療效率的現代醫療保健策略的關鍵組成部分。

全球智慧藥丸技術市場面臨的限制因素

儘管這項創新技術具有諸多優勢，但全球智慧藥丸技術市場的發展仍面臨一些挑戰。主要障礙包括膠囊內視鏡技術進步有限以及患者對吞服微晶片的擔憂。此外，可吞服感測器的高成本以及監管機構對這些設備更廣泛應用的嚴格監管措施也是一大障礙。這些因素綜合起來，預計將限制市場成長潛力，並阻礙智慧藥丸技術在醫療保健領域的更廣泛應用和整合。

全球智慧藥丸技術市場趨勢

全球智慧藥丸技術市場正經歷顯著成長，這主要得益於人工智慧物聯網解決方案（例如智慧藥丸提取系統 (SPES)）的進步。這個創新平台可自動管理藥物，同時提升易用性和即時診斷支持，有效解決藥物依從性差的問題——藥物依從性差是阻礙患者康復並增加醫療成本的一大難題。 SPES 相容於多種環境，包括養老院和居家醫療，並可同時有效管理多個用戶，方便家庭成員和醫護人員進行持續監測。該系統故障率極低，並具備強大的用戶身份驗證功能，優先考慮個人化用藥和可靠的健康預測，從而在醫療效率和患者安全方面樹立了新的標竿。

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較
主要企業簡介
- IntroMedic有限公司（韓國）
- CapsoVision公司（美國）
- Koninklijke Philips NV（荷蘭）
- 奧林巴斯株式會社（日本）
- RF株式會社（日本）
- HQ公司（美國）
- Proteus Digital Health（美國）
- 美敦力公司（愛爾蘭）
- 重慶金山科技（集團）有限公司（中國）
- 檢查-Cap 有限公司（以色列）
- AnX Robotica 公司（美國）
- 深圳市吉福醫療科技有限公司（中國）
- etecRx（美國）
- BodyCap（法國）
- 大塚美國製藥公司（美國）
- GE醫療（美國）
- 波士頓科學公司（美國）
- Given Imaging Ltd.（現為美敦力公司的一部分）（以色列）
- Bio-Images Research Limited（英國）
- Lucid Diagnostics（美國）

結論與建議

簡介目錄

Product Code: SQSG35H2020

Global Smart Pills Technology Market size was valued at USD 4.23 Billion in 2024 and is poised to grow from USD 4.59 Billion in 2025 to USD 8.82 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The global smart pill technology market showcases innovative digital capsules designed for advanced sensing, imaging, and medication delivery. These capsules, equipped with various sensors like biosensors and pH sensors, navigate the gastrointestinal tract, capturing essential diagnostic images that are difficult to access through conventional methods. Additionally, a connected wearable sensor patch enhances monitoring by linking to a provider portal and mobile app, facilitating a non-invasive alternative to traditional diagnostic techniques, such as endoscopy, particularly for cancer and gastrointestinal disorders. Furthermore, smart pills improve medication adherence and allow for the assessment of gastrointestinal conditions like gastroparesis. By wirelessly transmitting critical data, including vital signs and digestive metrics, these technologies revolutionize patient diagnosis and management, offering heightened flexibility for healthcare providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Pills Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Pills Technology Market Segments Analysis

Global Smart Pills Technology Market is segmented by Target Area, Disease Indication, Application, End User and region. Based on Target Area, the market is segmented into Esophagus, Stomach, Small Intestine and Large Intestine. Based on Disease Indication, the market is segmented into Barrett's Esophagus, Small Bowel Diseases, Colon Cancer and Others. Based on Application, the market is segmented into Capsule Endoscopy,Drug Delivery,Patient Monitoring and Others. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Pills Technology Market

The Global Smart Pills Technology market is poised for significant growth, fueled by the increasing incidence of gastrointestinal disorders, including motility issues, colon cancer, obscure gastrointestinal bleeding, and Crohn's disease. Additionally, the prevalence of sedentary lifestyles contributes to the demand for innovative solutions in healthcare. The appeal of smart pills lies in their ability to enhance patient compliance, attributed to their minimally invasive nature. As advancements in technology continue to evolve, these factors are driving a heightened interest in smart pill solutions, making them an essential component of modern healthcare strategies aimed at improving patient outcomes and treatment efficiency.

Restraints in the Global Smart Pills Technology Market

The growth of the Global Smart Pills Technology market faces several challenges despite the numerous benefits associated with this innovative technology. Key obstacles include limited technological advancements in capsule endoscopes, alongside patients' apprehension regarding the ingestion of microchips. Additionally, the high costs associated with ingestible sensors pose a significant barrier, as well as stringent regulatory measures imposed by authorities governing the increasing application of these devices. Collectively, these factors are anticipated to restrict the market's potential for expansion, hindering the broader adoption and integration of smart pill technology in healthcare practices.

Market Trends of the Global Smart Pills Technology Market

The Global Smart Pills Technology market is witnessing significant growth, driven by advancements in AI-IoT solutions like the Smart Pill Expert System (SPES). This innovative platform automates medication administration while enhancing user-friendliness and real-time diagnostic support, addressing the critical issue of medical non-adherence, which hampers recovery and elevates healthcare costs. By catering to diverse settings such as nursing homes and home healthcare, SPES effectively manages multiple users simultaneously, fostering continuous monitoring by family members and healthcare professionals. With a remarkably low failure rate and robust user authentication, the system prioritizes personalized medication delivery and reliable health predictions, setting a new benchmark in healthcare efficiency and patient safety.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis
Case Studies

Global Smart Pills Technology Market Size by Target Area & CAGR (2026-2033)

Market Overview
Esophagus
Stomach
Small Intestine
Large Intestine

Global Smart Pills Technology Market Size by Disease Indication & CAGR (2026-2033)

Market Overview
Barrett'S Esophagus
Small Bowel Diseases
Colon Cancer
Others

Global Smart Pills Technology Market Size by Application & CAGR (2026-2033)

Market Overview
Capsule Endoscopy
Drug Delivery
Patient Monitoring
Others

Global Smart Pills Technology Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals and Clinics
Diagnostic Centres
Research Centres

Global Smart Pills Technology Market Size & CAGR (2026-2033)

North America (Target Area, Disease Indication, Application, End User)
- US
- Canada
Europe (Target Area, Disease Indication, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Target Area, Disease Indication, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Target Area, Disease Indication, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Target Area, Disease Indication, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

IntroMedic Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapsoVision, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RF Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HQ, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteus Digital Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc. (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chongqing Jinshan Science & Technology (Group) Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Check-Cap Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AnX Robotica Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Jifu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
etecRx (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BodyCap (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Otsuka America Pharmaceutical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Given Imaging Ltd. (Now part of Medtronic) (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Images Research Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lucid Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments